ENDEAVOR II

Related by string. * endeavored . endeavoring . Endeavoring . Endeavors . endeavors . Endeavor . endeavor : Morris Endeavor . Endeavor stent . Mitsubishi Endeavor . artistic endeavors . Providers endeavor . entrepreneurial endeavors . Space Shuttle Endeavor / ii . IID . IIS . Ii . IIs . iis . IIED : World War II . Queen Elizabeth II . Dragon Age II . II Item 1A . Hangover Part II . Chart II . Godfather Part II * *

Related by context. Frequent words. (Click for all words.) 67 placebo controlled clinical 66 Pivotal Phase III 66 Pivotal Trial 65 SPIRIT III 64 Phase 2b study 63 Pivotal Phase 63 secondary efficacy endpoints 62 Endeavor stent 62 phase IIa 62 dose cohorts 61 PRECiSE 61 phase IIb 61 Phase 2a trial 61 Phase III Trial 61 Phase 1b trial 60 Coronary Stent 60 Azedra 60 Phase 2a clinical 60 placebo controlled studies 60 active comparator 60 Phase 1b 60 Phase 1b clinical 60 Phase IIa trial 60 Acute Myocardial Infarction 60 multicenter clinical 59 ponatinib 59 TRITON TIMI 59 Amrubicin 59 randomized controlled clinical 59 multicenter randomized double 59 elagolix 59 ADHF 59 Phase IIa 58 Phase 2a 58 Clinical Trial Results 58 sustained virologic response 58 Phase IIa clinical 58 tipranavir 58 Drug Eluting Stent 58 Completes Enrollment 58 phase 2a 58 TAXUS stent 58 PROMACTA 58 double blinded placebo 58 Immunogenicity 58 prospective observational 58 Pharmacokinetic 58 randomized controlled clinical trials 58 Phase III pivotal 58 mg kg dose 58 Phase Ib 58 nab paclitaxel 58 Drug Eluting Stents 58 bronchial thermoplasty 57 Phase 2b clinical 57 ACTEMRA 57 prospective randomized controlled 57 multicenter 57 Tolerability 57 CYPHER ® Stent 57 noninferiority 57 carotid artery stenting 57 CAPRISA 57 label multicenter 57 diabetic neuropathic pain 57 aclidinium 57 dose regimens 57 evaluable patients 57 Chronic Hepatitis C 57 mg QD 57 Endpoints 57 randomized Phase III 56 relapsed multiple myeloma 56 XIENCE V 56 multicenter randomized 56 relapsed refractory multiple myeloma 56 virologic 56 Solid Tumors 56 Phase III randomized 56 Stenting 56 TORISEL 56 axitinib 56 subgroup analyzes 56 confirmatory Phase 3 56 TAXUS 56 virologic response 56 Stedivaze 56 Phase 2b trial 56 dose escalation 56 GVAX 56 Phase 2b 56 rNAPc2 56 cytogenetic response 56 Clinical Outcomes 56 Monotherapy 56 MIRCERA 56 placebo controlled trials 56 eltrombopag 56 alvimopan 55 DSMB 55 Patients Treated

Back to home page